🇺🇸 FDA
Pipeline program

diazepam

199/11733

Phase 3 small_molecule completed

Quick answer

diazepam for Status Epilepticus is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Status Epilepticus
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials